Med-x (MXRX) DRS Draft registration statement

EXHIBIT 107

Calculation of Filing Fee Tables

S-1

(Form Type)

MED-X, INC.  

(Exact Name of Registrant as Specified in its Charter)

Common Stock Newly Registered and Carry Forward Securities

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial effective date

Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward

Newly Registered Securities

Fees to Be Paid

Equity

Common Stock  $0.001 par value per share(1)

457(o)

$

$92.70 per million

$

Fees to Be Paid

Equity

Common Stock  shares, $0.001 par value per share, underlying Representative’s  warrants(2)(3)

457(o)

$92.70 per million

$

Fees Previously Paid

—

—

—

—

—

—

—

—

—

—

—

—

Carry Forward Securities

Carry Forward Securities

Total Offering Amounts

$

$

Total Fees Previously Paid

—

Total Fee Offsets

—

Net Fee Due

$

(1)    Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) of the Securities Act of 1933, as amended. Includes shares to be sold upon exercise of the representative of the underwriters option to purchase additional shares. See “Underwriting.”  

(2)

We have agreed to issue the representative of the underwriters, upon closing of this offering, warrants to purchase up to 4% of the number of shares of common stock sold in this offering. The representative’s warrants are exercisable at a per share exercise price equal to 125% of the public offering price per share of the common stock offered hereby. As estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act, the proposed maximum aggregate offering price of the representative’s warrants is $     , which is equal to 120% of $     (4% of $    ) and assumes the exercise of the representative’s overallotment option in full. Resales of shares of common stock issuable upon exercise of the representative’s warrants are being similarly registered on a delayed or continuous basis.

(3)

No fee required pursuant to Rule 457(g).